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Supplementary Methods

Additional exclusion criteria
Patients were also excluded if they met any of the following criteria: 1) Presence of diarrhea attributed to any condition(s) other than carcinoid syndrome, including, but not limited to, fat malabsorption or bile acid 
Additional safety assessments
Investigators evaluated each adverse event and assigned an intensity using 1 of 3 severity grades:
Mild: aware of the event, but easily tolerated Moderate: enough discomfort to the patient to cause interference with usual activity Severe: incapacitating -the patient is unable to work or perform usual activities
Additional statistical methods
The blocked Wilcoxon rank-sum test was also used as the primary method to evaluate treatment group differences for secondary and other efficacy endpoints classified as continuous measures or as counts and the proportion of time that a particular outcome occurred.
Time-to-event endpoints used the log-rank test to evaluate treatment differences.
Cox's proportional hazards regression model was used to evaluate treatment effects in the presence of pertinent baseline covariates.
All statistical tests of treatment differences and related inferential summaries for the secondary and other efficacy endpoints were descriptive.
Additional preferred terms from Table 3
Injury, poisoning, and procedural complications includes post-procedural constipation, procedural nausea, procedural pain, ankle fracture, contusion, femur fracture, postembolization syndrome, post-procedural bile leak, post-procedural complication, vascular pseudoaneurysm, wound secretion, and arthropod bite.
Investigations also includes alanine aminotransferase increase, aspartate aminotransferase increase, blood alkaline phosphatase increase, blood lactic acid increase, blood magnesium decrease, blood phosphorus decrease, abnormal blood pressure, body temperature increase, Eastern Cooperative Oncology Group performance status, echocardiogram, hematocrit decrease, hepatic enzyme increase, abnormal liver function test, red blood cell count decrease, anticoagulation drug level below therapeutic, blood albumin decrease, blood thyroid-stimulating hormone increase, blood urea increase, C-reactive protein increase, cardiac murmur, creatinine renal clearance decrease, diagnostic procedure, electrocardiogram QT interval prolonged, electrocardiogram ST-T change, international normalized ratio increase, neutrophil count increase, protein total decreased, and white blood cell count increased.
Musculoskeletal and connective tissue disorders also includes muscle spasms, musculoskeletal chest pain, pain in extremity, bone pain, arthritis, bursitis, coccydynia, and flank pain.
Psychiatric disorders also includes anxiety, apathy, decreased interest, insomnia, nervousness, sleep disorders, agitation, confusional state, and restlessness.
